We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+14.54%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$30.8B
AUM Growth
+$518M
(+1.7%)
Cap. Flow
-$2.73B
Cap. Flow
% of AUM
-8.84%
Top 10 Holdings %
Top 10 Hldgs %
39.95%
Holding
1,143
New
66
Increased
528
Reduced
508
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$176M |
| 2 |
Credo Technology Group
CRDO
|
+$154M |
| 3 |
MACOM Technology Solutions
MTSI
|
+$71.5M |
| 4 |
Rambus
RMBS
|
+$69.5M |
| 5 |
NVMI
Nova
NVMI
|
+$68.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$386M |
| 2 |
NVIDIA
NVDA
|
+$300M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$272M |
| 4 |
Broadcom
AVGO
|
+$248M |
| 5 |
Qualcomm
QCOM
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.44% |
| 2 | Financials | 9.98% |
| 3 | Consumer Discretionary | 8.65% |
| 4 | Healthcare | 3.7% |
| 5 | Industrials | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Synchrony
SYF
$25.3B
| $9.18M | 0.03% |
129,274
-4,385
| -3% | -$318K |
|
302
Brown & Brown
BRO
$23.9B
| $9.15M | 0.03% |
97,513
+4,380
| +5% | +$427K |
|
303
Parker-Hannifin
PH
$124B
| $9.07M | 0.03% |
11,967
-133
| -1% | -$98.1K |
|
304
Exelixis
EXEL
$13.5B
| $9.01M | 0.03% |
218,164
-18,628
| -8% | -$749K |
|
305
VeriSign
VRSN
$27B
| $8.85M | 0.03% |
31,661
+1,944
| +7% | +$543K |
|
306
United Therapeutics
UTHR
$25.7B
| $8.84M | 0.03% |
21,082
-14,476
| -41% | -$4.87M |
|
307
NetApp
NTAP
$36B
| $8.66M | 0.03% |
73,143
-1,714
| -2% | -$192K |
|
308
HP
HPQ
$24.9B
| $8.62M | 0.03% |
316,689
+8,803
| +3% | +$235K |
|
309
Madrigal Pharmaceuticals
MDGL
$11B
| $8.58M | 0.03% |
18,715
-5,818
| -24% | -$2.17M |
|
310
Northern Trust
NTRS
$33.1B
| $8.57M | 0.03% |
63,641
-1,043
| -2% | -$134K |
|
311
Cigna
CI
$74B
| $8.54M | 0.03% |
29,627
+1,386
| +5% | +$410K |
|
312
Cboe Global Markets
CBOE
$31B
| $8.54M | 0.03% |
34,807
-12
| -0% | -$2.88K |
|
313
Texas Pacific Land
TPL
$27.5B
| $8.51M | 0.03% |
27,360
+63
| +0.2% | +$19.8K |
|
314
Commerce Bancshares
CBSH
$8.58B
| $8.49M | 0.03% |
149,252
+47,530
| +47% | +$2.79M |
|
315
Installed Building Products
IBP
$6.21B
| $8.49M | 0.03% |
34,437
+15,946
| +86% | +$3.79M |
|
316
Trane Technologies
TT
$101B
| $8.45M | 0.03% |
20,025
-114
| -0.6% | -$48.7K |
|
317
Revolution Medicines
RVMD
$39.3B
| $8.4M | 0.03% |
179,833
+26,855
| +18% | +$1.05M |
|
318
Neurocrine Biosciences
NBIX
$16.9B
| $8.24M | 0.03% |
58,701
-20,445
| -26% | -$2.77M |
|
319
Ionis Pharmaceuticals
IONS
$8.87B
| $8.23M | 0.03% |
125,773
-18,997
| -13% | -$927K |
|
320
Cincinnati Financial
CINF
$27.1B
| $8.23M | 0.03% |
52,040
+72
| +0.1% | +$10.9K |
|
321
PTC
PTC
$16.3B
| $8.2M | 0.03% |
40,389
+1,216
| +3% | +$248K |
|
322
BioMarin Pharmaceuticals
BMRN
$11.6B
| $8.18M | 0.03% |
151,015
-20,508
| -12% | -$1.17M |
|
323
Jabil
JBL
$33.2B
| $8.17M | 0.03% |
37,615
+283
| +0.8% | +$61.6K |
|
324
Elevance Health
ELV
$81.8B
| $8.08M | 0.03% |
25,001
+1,119
| +5% | +$348K |
|
|
CTRA
325
DELISTED
Coterra Energy
CTRA
| $8.08M | 0.03% |
341,573
-26,343
| -7% | -$635K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, Rafferty Asset Management held 1,143 positions worth $30.8B, up 1.7% from $30.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rafferty Asset Management withdrew a net $2.73B in Q3 2025, closing 39 positions and reducing 508 holdings. Its most notable exit was Qorvo, an estimated $103M position sold in full.
By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in Astera Labs worth $210M.
- Rafferty Asset Management's largest Q3 2025 buy was Astera Labs: 1,070,475 shares worth $210M.
- Rafferty Asset Management added most to Invesco QQQ Trust in Q3 2025, an estimated $42.9M increase.
- Rafferty Asset Management's biggest Q3 2025 reduction was Advanced Micro Devices, cutting an estimated $386M.
- Rafferty Asset Management fully exited Qorvo in Q3 2025, selling an estimated $103M.
- Rafferty Asset Management's ten largest holdings make up 40% of its $30.8B portfolio in Q3 2025.
- Rafferty Asset Management opened 66 new positions and closed 39 in Q3 2025.
- Rafferty Asset Management's portfolio value rose 1.7% quarter-over-quarter to $30.8B.
Based on Rafferty Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.